Article Information
History
- February 14, 2022.
Article Versions
- You are currently viewing Version 1 of this article (February 14, 2022 - 12:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Simone I. Richardson1,2,
- Vimbai Sharon Madzorera1,2,
- Holly Spencer1,2,
- Nelia P. Manamela1,2,
- Mieke A. van der Mescht3,
- Bronwen E. Lambson1,2,
- Brent Oosthuysen1,2,
- Frances Ayres1,2,
- Zanele Makhado1,2,
- Thandeka Moyo-Gwete1,2,
- Nonkululeko Mzindle1,2,
- Thopisang Motlou1,2,
- Amy Strydom4,
- Adriano Mendes4,
- Houriiyah Tegally5,
- Zelda de Beer6,
- Talita Roma de Villiers6,
- Annie Bodenstein6,
- Gretha van den Berg6,
- Marietjie Venter4,
- Tulio de Oliviera5,9,
- Veronica Ueckermann7,
- Theresa M. Rossouw3,
- Michael T. Boswell7 and
- Penny L. Moore1,2,8,9,*
- 1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa
- 2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa
- 3Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa
- 4Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, Department of Medical Virology, University of Pretoria, Pretoria, South Africa
- 5KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
- 6Tshwane District Hospital, Pretoria, South Africa
- 7Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa
- 8Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 9Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
- ↵* Corresponding author; email: pennym{at}nicd.ac.za
Posted February 14, 2022.
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals
Subject Area
Reviews and Context
2
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
23
Blogs/Media
Author Videos